nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—ESR1—liver cancer	0.711	1	CbGaD
Levonorgestrel—Quinestrol—ESR1—liver cancer	0.00112	0.141	CrCbGaD
Levonorgestrel—Ethynodiol—ESR1—liver cancer	0.000924	0.116	CrCbGaD
Levonorgestrel—Allylestrenol—ESR1—liver cancer	0.000872	0.11	CrCbGaD
Levonorgestrel—Mestranol—ESR1—liver cancer	0.00085	0.107	CrCbGaD
Levonorgestrel—Desogestrel—ESR1—liver cancer	0.00084	0.106	CrCbGaD
Levonorgestrel—Norgestimate—ESR1—liver cancer	0.000786	0.099	CrCbGaD
Levonorgestrel—Etonogestrel—ESR1—liver cancer	0.00068	0.0857	CrCbGaD
Levonorgestrel—Erythema—Sorafenib—liver cancer	0.000668	0.00462	CcSEcCtD
Levonorgestrel—Malnutrition—Sorafenib—liver cancer	0.000668	0.00462	CcSEcCtD
Levonorgestrel—Breast pain—Epirubicin—liver cancer	0.000648	0.00447	CcSEcCtD
Levonorgestrel—Amenorrhoea—Epirubicin—liver cancer	0.000643	0.00444	CcSEcCtD
Levonorgestrel—Muscle spasms—Sorafenib—liver cancer	0.000643	0.00444	CcSEcCtD
Levonorgestrel—Anaemia—Sorafenib—liver cancer	0.000618	0.00427	CcSEcCtD
Levonorgestrel—Herpes simplex—Epirubicin—liver cancer	0.000613	0.00424	CcSEcCtD
Levonorgestrel—Angioedema—Sorafenib—liver cancer	0.000611	0.00422	CcSEcCtD
Levonorgestrel—Syncope—Sorafenib—liver cancer	0.000599	0.00414	CcSEcCtD
Levonorgestrel—Breast pain—Doxorubicin—liver cancer	0.000599	0.00414	CcSEcCtD
Levonorgestrel—Amenorrhoea—Doxorubicin—liver cancer	0.000595	0.00411	CcSEcCtD
Levonorgestrel—Loss of consciousness—Sorafenib—liver cancer	0.000587	0.00406	CcSEcCtD
Levonorgestrel—Cough—Sorafenib—liver cancer	0.000583	0.00403	CcSEcCtD
Levonorgestrel—Hypertension—Sorafenib—liver cancer	0.000577	0.00399	CcSEcCtD
Levonorgestrel—Musculoskeletal pain—Epirubicin—liver cancer	0.000572	0.00395	CcSEcCtD
Levonorgestrel—Myalgia—Sorafenib—liver cancer	0.000569	0.00393	CcSEcCtD
Levonorgestrel—Herpes simplex—Doxorubicin—liver cancer	0.000567	0.00392	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000565	0.0039	CcSEcCtD
Levonorgestrel—Dermatitis contact—Epirubicin—liver cancer	0.000558	0.00386	CcSEcCtD
Levonorgestrel—Cystitis noninfective—Epirubicin—liver cancer	0.000552	0.00381	CcSEcCtD
Levonorgestrel—Influenza like illness—Epirubicin—liver cancer	0.000549	0.00379	CcSEcCtD
Levonorgestrel—Cystitis—Epirubicin—liver cancer	0.000546	0.00377	CcSEcCtD
Levonorgestrel—Infection—Sorafenib—liver cancer	0.000542	0.00374	CcSEcCtD
Levonorgestrel—Candida infection—Epirubicin—liver cancer	0.000539	0.00373	CcSEcCtD
Levonorgestrel—Shock—Sorafenib—liver cancer	0.000537	0.00371	CcSEcCtD
Levonorgestrel—Fluid retention—Epirubicin—liver cancer	0.000536	0.00371	CcSEcCtD
Levonorgestrel—Nervous system disorder—Sorafenib—liver cancer	0.000535	0.0037	CcSEcCtD
Levonorgestrel—Vaginal infection—Epirubicin—liver cancer	0.000533	0.00368	CcSEcCtD
Levonorgestrel—Skin disorder—Sorafenib—liver cancer	0.00053	0.00366	CcSEcCtD
Levonorgestrel—Musculoskeletal pain—Doxorubicin—liver cancer	0.000529	0.00366	CcSEcCtD
Levonorgestrel—Anorexia—Sorafenib—liver cancer	0.00052	0.00359	CcSEcCtD
Levonorgestrel—Cramps of lower extremities—Epirubicin—liver cancer	0.000519	0.00359	CcSEcCtD
Levonorgestrel—Dermatitis contact—Doxorubicin—liver cancer	0.000517	0.00357	CcSEcCtD
Levonorgestrel—Neoplasm—Epirubicin—liver cancer	0.000511	0.00353	CcSEcCtD
Levonorgestrel—Bladder pain—Epirubicin—liver cancer	0.000511	0.00353	CcSEcCtD
Levonorgestrel—Cystitis noninfective—Doxorubicin—liver cancer	0.000511	0.00353	CcSEcCtD
Levonorgestrel—Influenza like illness—Doxorubicin—liver cancer	0.000508	0.00351	CcSEcCtD
Levonorgestrel—Cystitis—Doxorubicin—liver cancer	0.000505	0.00349	CcSEcCtD
Levonorgestrel—Candida infection—Doxorubicin—liver cancer	0.000499	0.00345	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000497	0.00343	CcSEcCtD
Levonorgestrel—Fluid retention—Doxorubicin—liver cancer	0.000496	0.00343	CcSEcCtD
Levonorgestrel—Vaginal infection—Doxorubicin—liver cancer	0.000494	0.00341	CcSEcCtD
Levonorgestrel—Abnormal vision—Epirubicin—liver cancer	0.000493	0.0034	CcSEcCtD
Levonorgestrel—Dyspnoea—Sorafenib—liver cancer	0.000486	0.00336	CcSEcCtD
Levonorgestrel—Cramps of lower extremities—Doxorubicin—liver cancer	0.00048	0.00332	CcSEcCtD
Levonorgestrel—Dyspepsia—Sorafenib—liver cancer	0.00048	0.00332	CcSEcCtD
Levonorgestrel—Decreased appetite—Sorafenib—liver cancer	0.000474	0.00328	CcSEcCtD
Levonorgestrel—Neoplasm—Doxorubicin—liver cancer	0.000473	0.00327	CcSEcCtD
Levonorgestrel—Bladder pain—Doxorubicin—liver cancer	0.000473	0.00327	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Sorafenib—liver cancer	0.000471	0.00325	CcSEcCtD
Levonorgestrel—Fatigue—Sorafenib—liver cancer	0.00047	0.00325	CcSEcCtD
Levonorgestrel—Constipation—Sorafenib—liver cancer	0.000466	0.00322	CcSEcCtD
Levonorgestrel—Pain—Sorafenib—liver cancer	0.000466	0.00322	CcSEcCtD
Levonorgestrel—Vascular purpura—Epirubicin—liver cancer	0.000458	0.00317	CcSEcCtD
Levonorgestrel—Eczema—Epirubicin—liver cancer	0.000456	0.00315	CcSEcCtD
Levonorgestrel—Abnormal vision—Doxorubicin—liver cancer	0.000456	0.00315	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Sorafenib—liver cancer	0.000446	0.00308	CcSEcCtD
Levonorgestrel—Danazol—ESR1—liver cancer	0.000438	0.0552	CrCbGaD
Levonorgestrel—Increased appetite—Epirubicin—liver cancer	0.000437	0.00302	CcSEcCtD
Levonorgestrel—Urticaria—Sorafenib—liver cancer	0.000433	0.00299	CcSEcCtD
Levonorgestrel—Abdominal pain—Sorafenib—liver cancer	0.000431	0.00298	CcSEcCtD
Levonorgestrel—Body temperature increased—Sorafenib—liver cancer	0.000431	0.00298	CcSEcCtD
Levonorgestrel—Purpura—Epirubicin—liver cancer	0.000426	0.00294	CcSEcCtD
Levonorgestrel—Vascular purpura—Doxorubicin—liver cancer	0.000424	0.00293	CcSEcCtD
Levonorgestrel—Eczema—Doxorubicin—liver cancer	0.000422	0.00292	CcSEcCtD
Levonorgestrel—Pain in extremity—Epirubicin—liver cancer	0.00041	0.00283	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ESR1—liver cancer	0.000405	0.0511	CrCbGaD
Levonorgestrel—Increased appetite—Doxorubicin—liver cancer	0.000404	0.00279	CcSEcCtD
Levonorgestrel—Migraine—Epirubicin—liver cancer	0.000404	0.00279	CcSEcCtD
Levonorgestrel—Affect lability—Epirubicin—liver cancer	0.000404	0.00279	CcSEcCtD
Levonorgestrel—Hypersensitivity—Sorafenib—liver cancer	0.000402	0.00278	CcSEcCtD
Levonorgestrel—Purpura—Doxorubicin—liver cancer	0.000394	0.00272	CcSEcCtD
Levonorgestrel—Asthenia—Sorafenib—liver cancer	0.000391	0.0027	CcSEcCtD
Levonorgestrel—Mood swings—Epirubicin—liver cancer	0.000389	0.00268	CcSEcCtD
Levonorgestrel—Pruritus—Sorafenib—liver cancer	0.000386	0.00267	CcSEcCtD
Levonorgestrel—Pain in extremity—Doxorubicin—liver cancer	0.000379	0.00262	CcSEcCtD
Levonorgestrel—Dry skin—Epirubicin—liver cancer	0.000376	0.0026	CcSEcCtD
Levonorgestrel—Migraine—Doxorubicin—liver cancer	0.000374	0.00258	CcSEcCtD
Levonorgestrel—Affect lability—Doxorubicin—liver cancer	0.000374	0.00258	CcSEcCtD
Levonorgestrel—Diarrhoea—Sorafenib—liver cancer	0.000373	0.00258	CcSEcCtD
Levonorgestrel—Breast disorder—Epirubicin—liver cancer	0.000371	0.00256	CcSEcCtD
Levonorgestrel—Dizziness—Sorafenib—liver cancer	0.000361	0.00249	CcSEcCtD
Levonorgestrel—Mood swings—Doxorubicin—liver cancer	0.000359	0.00248	CcSEcCtD
Levonorgestrel—Abdominal distension—Epirubicin—liver cancer	0.000357	0.00247	CcSEcCtD
Levonorgestrel—Asthma—Epirubicin—liver cancer	0.000354	0.00245	CcSEcCtD
Levonorgestrel—Influenza—Epirubicin—liver cancer	0.000354	0.00245	CcSEcCtD
Levonorgestrel—Dry skin—Doxorubicin—liver cancer	0.000348	0.0024	CcSEcCtD
Levonorgestrel—Vomiting—Sorafenib—liver cancer	0.000347	0.0024	CcSEcCtD
Levonorgestrel—Rash—Sorafenib—liver cancer	0.000344	0.00238	CcSEcCtD
Levonorgestrel—Dermatitis—Sorafenib—liver cancer	0.000344	0.00237	CcSEcCtD
Levonorgestrel—Breast disorder—Doxorubicin—liver cancer	0.000343	0.00237	CcSEcCtD
Levonorgestrel—Headache—Sorafenib—liver cancer	0.000342	0.00236	CcSEcCtD
Levonorgestrel—Bronchitis—Epirubicin—liver cancer	0.000341	0.00235	CcSEcCtD
Levonorgestrel—Dysuria—Epirubicin—liver cancer	0.000331	0.00229	CcSEcCtD
Levonorgestrel—Abdominal distension—Doxorubicin—liver cancer	0.00033	0.00228	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Epirubicin—liver cancer	0.000329	0.00228	CcSEcCtD
Levonorgestrel—Asthma—Doxorubicin—liver cancer	0.000328	0.00227	CcSEcCtD
Levonorgestrel—Influenza—Doxorubicin—liver cancer	0.000328	0.00227	CcSEcCtD
Levonorgestrel—Pollakiuria—Epirubicin—liver cancer	0.000327	0.00226	CcSEcCtD
Levonorgestrel—Nausea—Sorafenib—liver cancer	0.000324	0.00224	CcSEcCtD
Levonorgestrel—Weight increased—Epirubicin—liver cancer	0.000323	0.00223	CcSEcCtD
Levonorgestrel—Weight decreased—Epirubicin—liver cancer	0.000321	0.00222	CcSEcCtD
Levonorgestrel—Pneumonia—Epirubicin—liver cancer	0.000318	0.0022	CcSEcCtD
Levonorgestrel—Infestation—Epirubicin—liver cancer	0.000316	0.00218	CcSEcCtD
Levonorgestrel—Infestation NOS—Epirubicin—liver cancer	0.000316	0.00218	CcSEcCtD
Levonorgestrel—Bronchitis—Doxorubicin—liver cancer	0.000315	0.00218	CcSEcCtD
Levonorgestrel—Urinary tract infection—Epirubicin—liver cancer	0.000307	0.00212	CcSEcCtD
Levonorgestrel—Dysuria—Doxorubicin—liver cancer	0.000307	0.00212	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000305	0.00211	CcSEcCtD
Levonorgestrel—Pollakiuria—Doxorubicin—liver cancer	0.000303	0.00209	CcSEcCtD
Levonorgestrel—Weight increased—Doxorubicin—liver cancer	0.000298	0.00206	CcSEcCtD
Levonorgestrel—Weight decreased—Doxorubicin—liver cancer	0.000297	0.00205	CcSEcCtD
Levonorgestrel—Sinusitis—Epirubicin—liver cancer	0.000297	0.00205	CcSEcCtD
Levonorgestrel—Pneumonia—Doxorubicin—liver cancer	0.000294	0.00203	CcSEcCtD
Levonorgestrel—Infestation—Doxorubicin—liver cancer	0.000292	0.00202	CcSEcCtD
Levonorgestrel—Infestation NOS—Doxorubicin—liver cancer	0.000292	0.00202	CcSEcCtD
Levonorgestrel—Haemoglobin—Epirubicin—liver cancer	0.000285	0.00197	CcSEcCtD
Levonorgestrel—Rhinitis—Epirubicin—liver cancer	0.000284	0.00196	CcSEcCtD
Levonorgestrel—Urinary tract infection—Doxorubicin—liver cancer	0.000284	0.00196	CcSEcCtD
Levonorgestrel—Haemorrhage—Epirubicin—liver cancer	0.000284	0.00196	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Epirubicin—liver cancer	0.000282	0.00195	CcSEcCtD
Levonorgestrel—Pharyngitis—Epirubicin—liver cancer	0.000282	0.00195	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Epirubicin—liver cancer	0.00028	0.00194	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Epirubicin—liver cancer	0.000279	0.00193	CcSEcCtD
Levonorgestrel—Urethral disorder—Epirubicin—liver cancer	0.000278	0.00192	CcSEcCtD
Levonorgestrel—Sinusitis—Doxorubicin—liver cancer	0.000274	0.0019	CcSEcCtD
Levonorgestrel—Visual impairment—Epirubicin—liver cancer	0.000273	0.00189	CcSEcCtD
Levonorgestrel—Erythema multiforme—Epirubicin—liver cancer	0.000268	0.00185	CcSEcCtD
Levonorgestrel—Eye disorder—Epirubicin—liver cancer	0.000265	0.00183	CcSEcCtD
Levonorgestrel—Haemoglobin—Doxorubicin—liver cancer	0.000264	0.00182	CcSEcCtD
Levonorgestrel—Cardiac disorder—Epirubicin—liver cancer	0.000263	0.00182	CcSEcCtD
Levonorgestrel—Rhinitis—Doxorubicin—liver cancer	0.000263	0.00182	CcSEcCtD
Levonorgestrel—Haemorrhage—Doxorubicin—liver cancer	0.000263	0.00181	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Doxorubicin—liver cancer	0.000261	0.0018	CcSEcCtD
Levonorgestrel—Pharyngitis—Doxorubicin—liver cancer	0.000261	0.0018	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Doxorubicin—liver cancer	0.000259	0.00179	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Doxorubicin—liver cancer	0.000258	0.00178	CcSEcCtD
Levonorgestrel—Urethral disorder—Doxorubicin—liver cancer	0.000257	0.00178	CcSEcCtD
Levonorgestrel—Immune system disorder—Epirubicin—liver cancer	0.000256	0.00177	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Epirubicin—liver cancer	0.000256	0.00177	CcSEcCtD
Levonorgestrel—Arrhythmia—Epirubicin—liver cancer	0.000253	0.00175	CcSEcCtD
Levonorgestrel—Visual impairment—Doxorubicin—liver cancer	0.000253	0.00175	CcSEcCtD
Levonorgestrel—Alopecia—Epirubicin—liver cancer	0.000251	0.00173	CcSEcCtD
Levonorgestrel—Mental disorder—Epirubicin—liver cancer	0.000249	0.00172	CcSEcCtD
Levonorgestrel—Erythema multiforme—Doxorubicin—liver cancer	0.000248	0.00171	CcSEcCtD
Levonorgestrel—Malnutrition—Epirubicin—liver cancer	0.000247	0.00171	CcSEcCtD
Levonorgestrel—Erythema—Epirubicin—liver cancer	0.000247	0.00171	CcSEcCtD
Levonorgestrel—Eye disorder—Doxorubicin—liver cancer	0.000245	0.00169	CcSEcCtD
Levonorgestrel—Cardiac disorder—Doxorubicin—liver cancer	0.000244	0.00168	CcSEcCtD
Levonorgestrel—Flatulence—Epirubicin—liver cancer	0.000243	0.00168	CcSEcCtD
Levonorgestrel—Tension—Epirubicin—liver cancer	0.000242	0.00167	CcSEcCtD
Levonorgestrel—Nervousness—Epirubicin—liver cancer	0.00024	0.00166	CcSEcCtD
Levonorgestrel—Back pain—Epirubicin—liver cancer	0.000239	0.00165	CcSEcCtD
Levonorgestrel—Muscle spasms—Epirubicin—liver cancer	0.000237	0.00164	CcSEcCtD
Levonorgestrel—Immune system disorder—Doxorubicin—liver cancer	0.000237	0.00164	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Doxorubicin—liver cancer	0.000237	0.00163	CcSEcCtD
Levonorgestrel—Arrhythmia—Doxorubicin—liver cancer	0.000235	0.00162	CcSEcCtD
Levonorgestrel—Alopecia—Doxorubicin—liver cancer	0.000232	0.0016	CcSEcCtD
Levonorgestrel—Mental disorder—Doxorubicin—liver cancer	0.00023	0.00159	CcSEcCtD
Levonorgestrel—Malnutrition—Doxorubicin—liver cancer	0.000229	0.00158	CcSEcCtD
Levonorgestrel—Erythema—Doxorubicin—liver cancer	0.000229	0.00158	CcSEcCtD
Levonorgestrel—Anaemia—Epirubicin—liver cancer	0.000228	0.00158	CcSEcCtD
Levonorgestrel—Progesterone—ESR1—liver cancer	0.000227	0.0286	CrCbGaD
Levonorgestrel—Flatulence—Doxorubicin—liver cancer	0.000225	0.00156	CcSEcCtD
Levonorgestrel—Tension—Doxorubicin—liver cancer	0.000224	0.00155	CcSEcCtD
Levonorgestrel—Nervousness—Doxorubicin—liver cancer	0.000222	0.00153	CcSEcCtD
Levonorgestrel—Vertigo—Epirubicin—liver cancer	0.000222	0.00153	CcSEcCtD
Levonorgestrel—Syncope—Epirubicin—liver cancer	0.000221	0.00153	CcSEcCtD
Levonorgestrel—Back pain—Doxorubicin—liver cancer	0.000221	0.00153	CcSEcCtD
Levonorgestrel—Muscle spasms—Doxorubicin—liver cancer	0.00022	0.00152	CcSEcCtD
Levonorgestrel—Palpitations—Epirubicin—liver cancer	0.000218	0.00151	CcSEcCtD
Levonorgestrel—Loss of consciousness—Epirubicin—liver cancer	0.000217	0.0015	CcSEcCtD
Levonorgestrel—Cough—Epirubicin—liver cancer	0.000216	0.00149	CcSEcCtD
Levonorgestrel—Hypertension—Epirubicin—liver cancer	0.000213	0.00147	CcSEcCtD
Levonorgestrel—Anaemia—Doxorubicin—liver cancer	0.000211	0.00146	CcSEcCtD
Levonorgestrel—Chest pain—Epirubicin—liver cancer	0.00021	0.00145	CcSEcCtD
Levonorgestrel—Myalgia—Epirubicin—liver cancer	0.00021	0.00145	CcSEcCtD
Levonorgestrel—Anxiety—Epirubicin—liver cancer	0.00021	0.00145	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000209	0.00144	CcSEcCtD
Levonorgestrel—Discomfort—Epirubicin—liver cancer	0.000208	0.00144	CcSEcCtD
Levonorgestrel—Vertigo—Doxorubicin—liver cancer	0.000205	0.00142	CcSEcCtD
Levonorgestrel—Syncope—Doxorubicin—liver cancer	0.000205	0.00142	CcSEcCtD
Levonorgestrel—Palpitations—Doxorubicin—liver cancer	0.000202	0.0014	CcSEcCtD
Levonorgestrel—Oedema—Epirubicin—liver cancer	0.000202	0.00139	CcSEcCtD
Levonorgestrel—Loss of consciousness—Doxorubicin—liver cancer	0.000201	0.00139	CcSEcCtD
Levonorgestrel—Infection—Epirubicin—liver cancer	0.0002	0.00138	CcSEcCtD
Levonorgestrel—Cough—Doxorubicin—liver cancer	0.000199	0.00138	CcSEcCtD
Levonorgestrel—Shock—Epirubicin—liver cancer	0.000198	0.00137	CcSEcCtD
Levonorgestrel—Nervous system disorder—Epirubicin—liver cancer	0.000198	0.00137	CcSEcCtD
Levonorgestrel—Hypertension—Doxorubicin—liver cancer	0.000197	0.00136	CcSEcCtD
Levonorgestrel—Skin disorder—Epirubicin—liver cancer	0.000196	0.00135	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Epirubicin—liver cancer	0.000195	0.00135	CcSEcCtD
Levonorgestrel—Chest pain—Doxorubicin—liver cancer	0.000195	0.00134	CcSEcCtD
Levonorgestrel—Myalgia—Doxorubicin—liver cancer	0.000195	0.00134	CcSEcCtD
Levonorgestrel—Anxiety—Doxorubicin—liver cancer	0.000194	0.00134	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000193	0.00133	CcSEcCtD
Levonorgestrel—Discomfort—Doxorubicin—liver cancer	0.000192	0.00133	CcSEcCtD
Levonorgestrel—Anorexia—Epirubicin—liver cancer	0.000192	0.00133	CcSEcCtD
Levonorgestrel—Oedema—Doxorubicin—liver cancer	0.000187	0.00129	CcSEcCtD
Levonorgestrel—Infection—Doxorubicin—liver cancer	0.000185	0.00128	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000184	0.00127	CcSEcCtD
Levonorgestrel—Shock—Doxorubicin—liver cancer	0.000183	0.00127	CcSEcCtD
Levonorgestrel—Nervous system disorder—Doxorubicin—liver cancer	0.000183	0.00126	CcSEcCtD
Levonorgestrel—Insomnia—Epirubicin—liver cancer	0.000182	0.00126	CcSEcCtD
Levonorgestrel—Progesterone—CYP1A1—liver cancer	0.000182	0.0229	CrCbGaD
Levonorgestrel—Skin disorder—Doxorubicin—liver cancer	0.000181	0.00125	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Doxorubicin—liver cancer	0.00018	0.00125	CcSEcCtD
Levonorgestrel—Dyspnoea—Epirubicin—liver cancer	0.00018	0.00124	CcSEcCtD
Levonorgestrel—Somnolence—Epirubicin—liver cancer	0.000179	0.00124	CcSEcCtD
Levonorgestrel—Anorexia—Doxorubicin—liver cancer	0.000178	0.00123	CcSEcCtD
Levonorgestrel—Dyspepsia—Epirubicin—liver cancer	0.000177	0.00123	CcSEcCtD
Levonorgestrel—Decreased appetite—Epirubicin—liver cancer	0.000175	0.00121	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Epirubicin—liver cancer	0.000174	0.0012	CcSEcCtD
Levonorgestrel—Fatigue—Epirubicin—liver cancer	0.000174	0.0012	CcSEcCtD
Levonorgestrel—Norethindrone—ALB—liver cancer	0.000173	0.0219	CrCbGaD
Levonorgestrel—Constipation—Epirubicin—liver cancer	0.000172	0.00119	CcSEcCtD
Levonorgestrel—Pain—Epirubicin—liver cancer	0.000172	0.00119	CcSEcCtD
Levonorgestrel—Testosterone—CYP1A1—liver cancer	0.000172	0.0216	CrCbGaD
Levonorgestrel—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00017	0.00117	CcSEcCtD
Levonorgestrel—Insomnia—Doxorubicin—liver cancer	0.000169	0.00117	CcSEcCtD
Levonorgestrel—Dyspnoea—Doxorubicin—liver cancer	0.000166	0.00115	CcSEcCtD
Levonorgestrel—Somnolence—Doxorubicin—liver cancer	0.000166	0.00115	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Epirubicin—liver cancer	0.000165	0.00114	CcSEcCtD
Levonorgestrel—Methyltestosterone—ALB—liver cancer	0.000165	0.0208	CrCbGaD
Levonorgestrel—Dyspepsia—Doxorubicin—liver cancer	0.000164	0.00113	CcSEcCtD
Levonorgestrel—Decreased appetite—Doxorubicin—liver cancer	0.000162	0.00112	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000161	0.00111	CcSEcCtD
Levonorgestrel—Fatigue—Doxorubicin—liver cancer	0.000161	0.00111	CcSEcCtD
Levonorgestrel—Urticaria—Epirubicin—liver cancer	0.00016	0.00111	CcSEcCtD
Levonorgestrel—Constipation—Doxorubicin—liver cancer	0.000159	0.0011	CcSEcCtD
Levonorgestrel—Pain—Doxorubicin—liver cancer	0.000159	0.0011	CcSEcCtD
Levonorgestrel—Body temperature increased—Epirubicin—liver cancer	0.000159	0.0011	CcSEcCtD
Levonorgestrel—Abdominal pain—Epirubicin—liver cancer	0.000159	0.0011	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Doxorubicin—liver cancer	0.000153	0.00105	CcSEcCtD
Levonorgestrel—Hypersensitivity—Epirubicin—liver cancer	0.000149	0.00103	CcSEcCtD
Levonorgestrel—Urticaria—Doxorubicin—liver cancer	0.000148	0.00102	CcSEcCtD
Levonorgestrel—Body temperature increased—Doxorubicin—liver cancer	0.000147	0.00102	CcSEcCtD
Levonorgestrel—Abdominal pain—Doxorubicin—liver cancer	0.000147	0.00102	CcSEcCtD
Levonorgestrel—Asthenia—Epirubicin—liver cancer	0.000145	0.000999	CcSEcCtD
Levonorgestrel—Pruritus—Epirubicin—liver cancer	0.000143	0.000985	CcSEcCtD
Levonorgestrel—Diarrhoea—Epirubicin—liver cancer	0.000138	0.000953	CcSEcCtD
Levonorgestrel—Hypersensitivity—Doxorubicin—liver cancer	0.000137	0.000949	CcSEcCtD
Levonorgestrel—Asthenia—Doxorubicin—liver cancer	0.000134	0.000924	CcSEcCtD
Levonorgestrel—Dizziness—Epirubicin—liver cancer	0.000133	0.000921	CcSEcCtD
Levonorgestrel—Pruritus—Doxorubicin—liver cancer	0.000132	0.000912	CcSEcCtD
Levonorgestrel—Vomiting—Epirubicin—liver cancer	0.000128	0.000885	CcSEcCtD
Levonorgestrel—Diarrhoea—Doxorubicin—liver cancer	0.000128	0.000882	CcSEcCtD
Levonorgestrel—Rash—Epirubicin—liver cancer	0.000127	0.000878	CcSEcCtD
Levonorgestrel—Dermatitis—Epirubicin—liver cancer	0.000127	0.000877	CcSEcCtD
Levonorgestrel—Headache—Epirubicin—liver cancer	0.000126	0.000872	CcSEcCtD
Levonorgestrel—Dizziness—Doxorubicin—liver cancer	0.000123	0.000852	CcSEcCtD
Levonorgestrel—Nausea—Epirubicin—liver cancer	0.00012	0.000827	CcSEcCtD
Levonorgestrel—Vomiting—Doxorubicin—liver cancer	0.000119	0.000819	CcSEcCtD
Levonorgestrel—Rash—Doxorubicin—liver cancer	0.000118	0.000812	CcSEcCtD
Levonorgestrel—Dermatitis—Doxorubicin—liver cancer	0.000117	0.000812	CcSEcCtD
Levonorgestrel—Headache—Doxorubicin—liver cancer	0.000117	0.000807	CcSEcCtD
Levonorgestrel—Nausea—Doxorubicin—liver cancer	0.000111	0.000765	CcSEcCtD
Levonorgestrel—Testosterone—ALB—liver cancer	9.56e-05	0.0121	CrCbGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	7.01e-05	0.000515	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	6.98e-05	0.000513	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FST—liver cancer	6.97e-05	0.000512	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARA—liver cancer	6.93e-05	0.000509	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	6.83e-05	0.000502	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—SERPINE1—liver cancer	6.78e-05	0.000498	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CB—liver cancer	6.75e-05	0.000496	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TRIO—liver cancer	6.65e-05	0.000489	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	6.65e-05	0.000488	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	6.62e-05	0.000486	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	6.58e-05	0.000483	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	6.56e-05	0.000482	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	6.52e-05	0.000479	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	6.49e-05	0.000477	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GLUL—liver cancer	6.47e-05	0.000475	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CPT1B—liver cancer	6.47e-05	0.000475	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR4—liver cancer	6.38e-05	0.000468	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HNF4A—liver cancer	6.35e-05	0.000467	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	6.32e-05	0.000464	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	6.31e-05	0.000464	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	6.3e-05	0.000463	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—ESR1—liver cancer	6.28e-05	0.000461	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	6.26e-05	0.000459	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NR1H4—liver cancer	6.24e-05	0.000458	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTA3—liver cancer	6.13e-05	0.000451	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	6.13e-05	0.00045	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MYC—liver cancer	6.11e-05	0.000449	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	6.11e-05	0.000449	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	6.08e-05	0.000446	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	5.96e-05	0.000438	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—liver cancer	5.81e-05	0.000427	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.8e-05	0.000426	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—liver cancer	5.73e-05	0.000421	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	5.72e-05	0.00042	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—liver cancer	5.65e-05	0.000415	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—KRAS—liver cancer	5.62e-05	0.000413	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTA4—liver cancer	5.61e-05	0.000412	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	5.61e-05	0.000412	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.58e-05	0.00041	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PSMA4—liver cancer	5.55e-05	0.000408	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PSMD10—liver cancer	5.55e-05	0.000408	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	5.51e-05	0.000404	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	5.5e-05	0.000404	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.48e-05	0.000403	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTA2—liver cancer	5.47e-05	0.000402	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	5.4e-05	0.000397	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARA—liver cancer	5.34e-05	0.000392	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GGT1—liver cancer	5.33e-05	0.000391	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTA1—liver cancer	5.27e-05	0.000387	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SHC3—liver cancer	5.27e-05	0.000387	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NAT2—liver cancer	5.22e-05	0.000383	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PIK3CA—liver cancer	5.16e-05	0.000379	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—SERPINE1—liver cancer	5.16e-05	0.000379	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.07e-05	0.000372	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.05e-05	0.000371	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADAM17—liver cancer	5.04e-05	0.00037	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—liver cancer	5.02e-05	0.000369	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.02e-05	0.000368	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALDOB—liver cancer	5e-05	0.000367	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—H2AFX—liver cancer	4.92e-05	0.000362	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HNF4A—liver cancer	4.9e-05	0.00036	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.78e-05	0.000351	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—HRAS—liver cancer	4.78e-05	0.000351	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CRABP1—liver cancer	4.77e-05	0.00035	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PSMA4—liver cancer	4.74e-05	0.000348	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PSMD10—liver cancer	4.74e-05	0.000348	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	4.74e-05	0.000348	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.72e-05	0.000347	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.72e-05	0.000346	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.68e-05	0.000344	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—liver cancer	4.57e-05	0.000336	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.56e-05	0.000335	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—liver cancer	4.41e-05	0.000324	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.4e-05	0.000323	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARA—liver cancer	4.38e-05	0.000322	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.34e-05	0.000318	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.3e-05	0.000316	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.3e-05	0.000315	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—liver cancer	4.29e-05	0.000315	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PSMA4—liver cancer	4.28e-05	0.000314	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PSMD10—liver cancer	4.28e-05	0.000314	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—liver cancer	4.24e-05	0.000311	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—liver cancer	4.22e-05	0.00031	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HPGDS—liver cancer	4.17e-05	0.000306	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.17e-05	0.000306	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.16e-05	0.000306	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.15e-05	0.000304	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CA—liver cancer	4.11e-05	0.000302	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.11e-05	0.000302	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FST—liver cancer	4.09e-05	0.000301	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAPK14—liver cancer	4.05e-05	0.000297	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SERPINE1—liver cancer	3.98e-05	0.000292	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—ESR1—liver cancer	3.97e-05	0.000292	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TRIO—liver cancer	3.9e-05	0.000287	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.78e-05	0.000277	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—H2AFX—liver cancer	3.75e-05	0.000276	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR4—liver cancer	3.74e-05	0.000275	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.73e-05	0.000274	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PSMA4—liver cancer	3.72e-05	0.000273	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PSMD10—liver cancer	3.72e-05	0.000273	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCE—liver cancer	3.67e-05	0.00027	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—liver cancer	3.62e-05	0.000266	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GOT2—liver cancer	3.62e-05	0.000266	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.51e-05	0.000258	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF2—liver cancer	3.48e-05	0.000256	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2E1—liver cancer	3.4e-05	0.00025	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—liver cancer	3.36e-05	0.000247	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARA—liver cancer	3.34e-05	0.000245	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.29e-05	0.000242	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—liver cancer	3.27e-05	0.00024	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SERPINE1—liver cancer	3.26e-05	0.00024	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CSF2—liver cancer	3.25e-05	0.000239	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—H2AFX—liver cancer	3.2e-05	0.000235	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYCS—liver cancer	3.18e-05	0.000234	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GOT1—liver cancer	3.12e-05	0.000229	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GGT1—liver cancer	3.12e-05	0.000229	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UGDH—liver cancer	3.12e-05	0.000229	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAPK14—liver cancer	3.08e-05	0.000226	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ESR1—liver cancer	3.02e-05	0.000222	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADAM17—liver cancer	2.96e-05	0.000217	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EPT1—liver cancer	2.93e-05	0.000215	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TERT—liver cancer	2.9e-05	0.000213	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—H2AFX—liver cancer	2.89e-05	0.000212	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTP1—liver cancer	2.8e-05	0.000206	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSMA4—liver cancer	2.78e-05	0.000204	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSMD10—liver cancer	2.78e-05	0.000204	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TAT—liver cancer	2.78e-05	0.000204	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—liver cancer	2.76e-05	0.000203	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—liver cancer	2.76e-05	0.000203	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KDR—liver cancer	2.65e-05	0.000195	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK14—liver cancer	2.63e-05	0.000193	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ESR1—liver cancer	2.58e-05	0.00019	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—liver cancer	2.58e-05	0.000189	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARA—liver cancer	2.57e-05	0.000189	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—liver cancer	2.55e-05	0.000187	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—liver cancer	2.52e-05	0.000185	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—liver cancer	2.49e-05	0.000183	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A1—liver cancer	2.44e-05	0.000179	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APC—liver cancer	2.44e-05	0.000179	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CG—liver cancer	2.44e-05	0.000179	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAPK14—liver cancer	2.37e-05	0.000174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BRAF—liver cancer	2.29e-05	0.000168	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—liver cancer	2.28e-05	0.000167	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARA—liver cancer	2.23e-05	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCE—liver cancer	2.16e-05	0.000158	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CD—liver cancer	2.14e-05	0.000158	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—liver cancer	2.13e-05	0.000156	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—liver cancer	2.12e-05	0.000156	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—liver cancer	2.06e-05	0.000152	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF2—liver cancer	2.04e-05	0.00015	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.01e-05	0.000147	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—liver cancer	1.91e-05	0.000141	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RAF1—liver cancer	1.91e-05	0.000141	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CG—liver cancer	1.91e-05	0.00014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CSF2—liver cancer	1.91e-05	0.00014	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CPT1B—liver cancer	1.89e-05	0.000139	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GLUL—liver cancer	1.89e-05	0.000139	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—H2AFX—liver cancer	1.88e-05	0.000138	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MTOR—liver cancer	1.87e-05	0.000137	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CB—liver cancer	1.87e-05	0.000137	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—liver cancer	1.85e-05	0.000136	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NR1H4—liver cancer	1.82e-05	0.000134	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA3—liver cancer	1.79e-05	0.000131	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1B—liver cancer	1.75e-05	0.000129	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—liver cancer	1.72e-05	0.000126	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—liver cancer	1.72e-05	0.000126	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TERT—liver cancer	1.7e-05	0.000125	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CD—liver cancer	1.68e-05	0.000123	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—liver cancer	1.67e-05	0.000123	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUN—liver cancer	1.67e-05	0.000123	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—liver cancer	1.66e-05	0.000122	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CTNNB1—liver cancer	1.66e-05	0.000122	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA4—liver cancer	1.64e-05	0.00012	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—liver cancer	1.62e-05	0.000119	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1A—liver cancer	1.62e-05	0.000119	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA2—liver cancer	1.6e-05	0.000117	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK8—liver cancer	1.58e-05	0.000116	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—liver cancer	1.57e-05	0.000116	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KDR—liver cancer	1.55e-05	0.000114	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK14—liver cancer	1.54e-05	0.000113	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA1—liver cancer	1.54e-05	0.000113	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAT2—liver cancer	1.52e-05	0.000112	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—liver cancer	1.5e-05	0.00011	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CB—liver cancer	1.47e-05	0.000108	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDOB—liver cancer	1.46e-05	0.000107	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—liver cancer	1.46e-05	0.000107	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—liver cancer	1.44e-05	0.000106	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APC—liver cancer	1.43e-05	0.000105	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.43e-05	0.000105	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—liver cancer	1.43e-05	0.000105	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CRABP1—liver cancer	1.39e-05	0.000102	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BRAF—liver cancer	1.35e-05	9.88e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—liver cancer	1.34e-05	9.86e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—liver cancer	1.34e-05	9.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CD—liver cancer	1.26e-05	9.24e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—liver cancer	1.25e-05	9.14e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KRAS—liver cancer	1.24e-05	9.11e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HPGDS—liver cancer	1.22e-05	8.94e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—liver cancer	1.21e-05	8.9e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—liver cancer	1.14e-05	8.37e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RAF1—liver cancer	1.12e-05	8.25e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—liver cancer	1.1e-05	8.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CB—liver cancer	1.1e-05	8.06e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTOR—liver cancer	1.1e-05	8.06e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—liver cancer	1.09e-05	8.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSMA4—liver cancer	1.08e-05	7.97e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSMD10—liver cancer	1.08e-05	7.97e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GOT2—liver cancer	1.06e-05	7.75e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HRAS—liver cancer	1.05e-05	7.74e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1B—liver cancer	1.03e-05	7.56e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—liver cancer	1.01e-05	7.41e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—liver cancer	1.01e-05	7.41e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—liver cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2E1—liver cancer	9.92e-06	7.29e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—liver cancer	9.82e-06	7.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUN—liver cancer	9.8e-06	7.2e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CTNNB1—liver cancer	9.73e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—liver cancer	9.54e-06	7e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1A—liver cancer	9.5e-06	6.98e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—liver cancer	9.31e-06	6.84e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYCS—liver cancer	9.28e-06	6.82e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK8—liver cancer	9.27e-06	6.81e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GOT1—liver cancer	9.11e-06	6.69e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GGT1—liver cancer	9.11e-06	6.69e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—liver cancer	8.93e-06	6.56e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—liver cancer	8.56e-06	6.29e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—liver cancer	8.48e-06	6.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—liver cancer	8.4e-06	6.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTP1—liver cancer	8.18e-06	6.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—liver cancer	8.07e-06	5.93e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—liver cancer	7.88e-06	5.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—liver cancer	7.86e-06	5.77e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—liver cancer	7.52e-06	5.52e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—liver cancer	7.3e-06	5.36e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KRAS—liver cancer	7.28e-06	5.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1A1—liver cancer	7.13e-06	5.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—liver cancer	6.69e-06	4.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—liver cancer	6.64e-06	4.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARA—liver cancer	6.52e-06	4.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—liver cancer	6.47e-06	4.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRAS—liver cancer	6.19e-06	4.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—liver cancer	5.92e-06	4.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CG—liver cancer	5.58e-06	4.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—liver cancer	5.46e-06	4.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—liver cancer	5.39e-06	3.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CD—liver cancer	4.91e-06	3.6e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—liver cancer	4.84e-06	3.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CB—liver cancer	4.28e-06	3.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—liver cancer	2.61e-06	1.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—liver cancer	2.13e-06	1.56e-05	CbGpPWpGaD
